ImmunityBio Jumps Again as Traders Look to Anktiva News
ImmunityBio shares traded higher Thursday afternoon, holding close to $7.40. Investors sifted through new SEC filings while also watching for the latest clinical news on Anktiva, the company’s bladder-cancer immunotherapy. The stock added 3.0% to $7.395, with a range from $7.07 to $7.47 on the day. Volume came in at around 5.8 million shares. SPDR S&P Biotech ETF was up 2.6% and the iShares Nasdaq Biotechnology ETF climbed 2.1%. The Nasdaq-100 ETF QQQ gave up 0.3%.